tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2021 May 19;1-6.
doi: 10.1080/21645515.2021.1924018. Online ahead of print.
"This choice does not just affect me." Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study
Sarah Geoghegan[SUP] 1 2 3 [/SUP], Laura C Stephens[SUP] 4 [/SUP], Kristen A Feemster[SUP] 2 5 [/SUP], Richard J Drew[SUP] 6 [/SUP], Maeve Eogan[SUP] 7 [/SUP], Karina M Butler[SUP] 1 3 [/SUP]
Affiliations
Abstract
Public health experts agree that pregnant women who fall into priority groups may be offered a Coronavirus Disease 2019 (COVID-19) vaccine. However, little is known about attitudes of pregnant women toward COVID-19 vaccination. We surveyed 300 pregnant women during the roll out of the Pfizer-BioNTech vaccine in Ireland. Women rated likelihood of receipt of a vaccine during pregnancy, on a 1-10 scale (1 = very unlikely, 10 = very likely). One hundred and thirteen (38%) women responded with a score of ?8, while a similar proportion (36%) selected a score of ?2. Safety of their unborn infant was the primary driver of decision making among survey participants, but specific safety concerns differed according to likely acceptance of a vaccine. Communication about COVID-19 vaccines to pregnant women must explicitly address safety. Pregnant women and their health-care providers should be supported with accessible interpretations of data so that they can make the best choice for their individual risk profile.
Keywords: COVID-19; Vaccine; attitudes; pregnancy; pregnant women; vaccine safety.
. 2021 May 19;1-6.
doi: 10.1080/21645515.2021.1924018. Online ahead of print.
"This choice does not just affect me." Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study
Sarah Geoghegan[SUP] 1 2 3 [/SUP], Laura C Stephens[SUP] 4 [/SUP], Kristen A Feemster[SUP] 2 5 [/SUP], Richard J Drew[SUP] 6 [/SUP], Maeve Eogan[SUP] 7 [/SUP], Karina M Butler[SUP] 1 3 [/SUP]
Affiliations
- PMID: 34009096
- DOI: 10.1080/21645515.2021.1924018
Abstract
Public health experts agree that pregnant women who fall into priority groups may be offered a Coronavirus Disease 2019 (COVID-19) vaccine. However, little is known about attitudes of pregnant women toward COVID-19 vaccination. We surveyed 300 pregnant women during the roll out of the Pfizer-BioNTech vaccine in Ireland. Women rated likelihood of receipt of a vaccine during pregnancy, on a 1-10 scale (1 = very unlikely, 10 = very likely). One hundred and thirteen (38%) women responded with a score of ?8, while a similar proportion (36%) selected a score of ?2. Safety of their unborn infant was the primary driver of decision making among survey participants, but specific safety concerns differed according to likely acceptance of a vaccine. Communication about COVID-19 vaccines to pregnant women must explicitly address safety. Pregnant women and their health-care providers should be supported with accessible interpretations of data so that they can make the best choice for their individual risk profile.
Keywords: COVID-19; Vaccine; attitudes; pregnancy; pregnant women; vaccine safety.